[1] Roda G,Chien Ng S,Kotze P G,et al.Crohn's disease[J].Nat Rev Dis Primers,2020,6(1):22. [2] Bakke D,Sun J.Ancient nuclear receptor VDR with new functions:microbiome and inflammation[J].Inflamm Bowel Dis,2018,24(6):1149-1154. [3] Kobayashi T,Siegmund B,Le Berre C,et al.Ulcerative colitis[J].Nat Rev Dis Primers,2020,6(1):74. [4] Krug S M,Bojarski C,Fromm A,et al.Tricellulin is regulated via interleukin-13-receptor alpha2,affects macromolecule uptake,and is decreased in ulcerative colitis[J].Mucosal Immunol,2018,11(2):345-356. [5] De Martinis M,Allegra A,Sirufo M M,et al.Vitamin D deficiency,osteoporosis and effect on autoimmune diseases and hematopoiesis:a review[J].Int Mol Sci,2021,22(16):8855. [6] Barbalho S M,Goulart R A,Gasparini R G.Associations between inflammatory bowel diseases and vitamin D[J].Crit Rev Food Sci Nutr,2019,59(8):1347-1356. [7] 荆扬,石永强,张家琦,等.外源性维生素D对炎症性肠病患者肠道黏膜屏障和炎症因子水平的影响[J].胃肠病学,2019,24(8):493-496. [8] Krela-Kazmierczak I,Szymczak-Tomczak A,Tomczak M,et al.Is there a relation between vitamin D,interleukin-17,and bone mineral density in patients with inflammatory bowel disease?[J].Arch Med Sci,2021,17(3):662-674. [9] Konya V,Czarnewski P,Forkel M,et al.Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells[J].Allergy Clin Immunol,2018,141(1):279-292. [10] Moschen A R,Tilg H,Raine T.IL-12,IL-23 and IL-17 in IBD:immunobiology and therapeutic targeting[J].Nat Rev Gastroenterol Hepatol,2019,16(3):185-196. [11] Kojecky V,Matous J,Kianicka B,et al.Vitamin D levels in IBD:a randomised trial of weight-based versus fixed dose vitamin D supplementation[J].Scand Gastroenterol,2020,55(6):671-676.
2023, Vol. 29 
冀公网安备13080202000677号